Get started
Author

Shanchun Guo

CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications
2011 · Mingli Liu, Shanchun Guo, et al. · Cytokine & Growth Factor Reviews · 840
PDF
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
2015 · Mark A. Feitelson, Alla Arzumanyan, et al. · Seminars in Cancer Biology · 825
PDF
The emerging role of CXCL10 in cancer (Review)
2011 · MINGLI LIU, SHANCHUN GUO, et al. · Oncology Letters · 438
PDF
Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
2017 · Weiqiang Zhou, Shanchun Guo, et al. · Current Medicinal Chemistry · 301
Role of Notch and its oncogenic signaling crosstalk in breast cancer
2010 · Shanchun Guo, Mingli Liu, et al. · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 274
Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells
2003 · Jose Russo, M. Hasan Lareef, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 257
Vascular endothelial growth factor receptor-2 in breast cancer
2010 · Shanchun Guo, Laronna S. Colbert, et al. · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 250
Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFκB/HIF-1α activation
2010 · Ruben R. Gonzalez-Perez, Yanbo Xu, et al. · Cellular Signalling · 174
Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells
2012 · Shanchun Guo, Mingli Liu, et al. · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 142
Notch, IL-1 and Leptin Crosstalk Outcome (NILCO) Is Critical for Leptin-Induced Proliferation, Migration and VEGF/VEGFR-2 Expression in Breast Cancer
2011 · Shanchun Guo, Ruben R. Gonzalez-Perez · PLoS ONE · 140
PDF
TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways
2014 · Mingli Liu, Koichi Inoue, et al. · Cellular Signalling · 122
Glutathione peroxidases as oncotargets
2017 · Yang Jiao, Yirong Wang, et al. · Oncotarget · 95
PDF
Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD)
2016 · Jiawang Liu, Shilong Zheng, et al. · Journal of Medicinal Chemistry · 89
Galactosylation of N-linked oligosaccharides by human -1,4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells
2001 · S. Guo, T. Sato, et al. · Glycobiology · 84
Linking Transcriptional Elongation and Messenger RNA Export to Metastatic Breast Cancers
2005 · Shanchun Guo, Mohamed-Ali Hakimi, et al. · Cancer Research · 78
PDF
INPP4B is an oncogenic regulator in human colon cancer
2015 · S T Guo, M N Chi, et al. · Oncogene · 65
PDF
Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells
2013 · Weiqiang Zhou, Guangdi Wang, et al. · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 56
17β-Estradiol-Mediated Vessel Assembly and Stabilization in Tumor Angiogenesis Requires TGFβ and EGFR Crosstalk
2003 · Raquel Soares, Shanchun Guo, et al. · Angiogenesis · 51
Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors
2018 · Shilong Zheng, Shanchun Guo, et al. · ACS Medicinal Chemistry Letters · 46
ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft models
2018 · Shanchun Guo, Changde Zhang, et al. · Oncotarget · 45
PDF
TRPM7 Induces Mechanistic Target of Rap1b Through the Downregulation of miR-28-5p in Glioma Proliferation and Invasion
2019 · Jingwei Wan, Alyssa Aihui Guo, et al. · Frontiers in Oncology · 44
PDF
Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells
2016 · Weiqiang Zhou, Xiuyan Feng, et al. · Scientific Reports · 43
PDF
Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor Downregulator
2016 · Jiawang Liu, Shilong Zheng, et al. · ACS Medicinal Chemistry Letters · 42
LncRNA HOTAIR sponges miR-301a-3p to promote glioblastoma proliferation and invasion through upregulating FOSL1
2022 · Shanchun Guo, Pendelton King, et al. · Cellular Signalling · 39
Advances in the proteomic discovery of novel therapeutic targets in cancer
2013 · Shanchun Guo, Jin Zou, et al. · Drug Design Development and Therapy · 36
Works count: 111
Citation count: 5,234
H-index: 28
I10-index: 53
Year
Topic
Type